Micah James Evans Gliedt

Title: Micah James Evans Gliedt: Innovator in mTOR Inhibitors

Introduction

Micah James Evans Gliedt is a prominent inventor based in Redwood City, CA (US). He has made significant contributions to the field of pharmaceuticals, particularly in the development of mTOR inhibitors. With a total of 3 patents to his name, Gliedt is recognized for his innovative approaches to treating diseases mediated by mTOR.

Latest Patents

One of Gliedt's latest patents is focused on C26-linked rapamycin analogs as mTOR inhibitors. This patent details compounds and compositions that inhibit mTOR, along with methods for treating diseases associated with mTOR. The embodiments outlined in this patent provide valuable insights into synthesizing these compounds, showcasing Gliedt's expertise in the field.

Career Highlights

Gliedt is currently associated with Revolution Medicines, Inc., where he continues to push the boundaries of pharmaceutical innovation. His work has been instrumental in advancing the understanding and application of mTOR inhibitors in medical treatments.

Collaborations

Throughout his career, Gliedt has collaborated with notable colleagues, including Jennifer Pitzen and G Leslie Burnett. These partnerships have further enriched his research and development efforts in the pharmaceutical industry.

Conclusion

Micah James Evans Gliedt stands out as a key figure in the development of mTOR inhibitors, with a strong patent portfolio and impactful collaborations. His work at Revolution Medicines, Inc. continues to influence the landscape of medical treatments.